Literature DB >> 29421802

Postoperative Liver Failure Criteria for Predicting Mortality after Major Hepatectomy with Extrahepatic Bile Duct Resection.

Takeshi Kawamura1, Takehiro Noji2, Keisuke Okamura1, Kimitaka Tanaka1, Yoshitsugu Nakanishi1, Toshimichi Asano1, Yuma Ebihara1, Yo Kurashima1, Toru Nakamura1, Soichi Murakami1, Takahiro Tsuchikawa1, Toshiaki Shichinohe1, Satoshi Hirano1.   

Abstract

BACKGROUND: Post-hepatectomy liver failure (PHLF) is a serious complication after major hepatectomy with extrahepatic bile duct resection (Hx with EBDR) that may cause severe morbidity and even death. The purpose of this study was to compare several criteria systems as predictors of PHLF-related mortality following Hx with EBDR for perihilar cholangiocarcinoma (PHCC).
METHODS: The study cohort consisted of 222 patients who underwent Hx with EBDR for PHCC. We compared several criteria systems, including previously established criteria (the International Study Group of Liver Surgery (ISGLS) criterion; and the "50-50" criterion), and our institution's novel systems "Max T-Bili" defined as total bilirubin (T-Bili) >7.3 mg/dL during post-operative days (POD) 1-7, and the "3-4-50" criterion, defined as total bilirubin >4 mg/dL and prothrombin time <50% on POD #3.
RESULTS: Thirteen patients (5.8%) died from PHLF-related causes. The 3-4-50 criterion showed high positive predictive values (39.1%), the 3-4-50, Max T-Bili, and 50-50 criterion showed high accuracies (91.7, 86.9, and 90.5%, respectively) and varying sensitivities (69.2, 69.2, and 38.5% respectively).
CONCLUSIONS: The 3-4-50, Max T-Bili, and 50-50 criterion were all useful for predicting PHLF-related mortality after Hx with EBDR for PHCC.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  50-50 criterion; International Study Group of Liver Surgery criterion; Mortality; Perihilar cholangiocarcinoma; Postoperative liver failure

Mesh:

Substances:

Year:  2018        PMID: 29421802     DOI: 10.1159/000486906

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  4 in total

1.  Transhepatic Direct Approach to the "Limit of the Division of the Hepatic Ducts" Leads to a High R0 Resection Rate in Perihilar Cholangiocarcinoma.

Authors:  Takehiro Noji; Kimitaka Tanaka; Aya Matsui; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Satoshi Hirano
Journal:  J Gastrointest Surg       Date:  2021-01-05       Impact factor: 3.452

2.  Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.

Authors:  Takehiro Noji; Satoko Uemura; Jimme K Wiggers; Kimitaka Tanaka; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Pim B Olthof; William R Jarnagin; Thomas M van Gulik; Satoshi Hirano
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

3.  Differences in the safety line of the future liver remnant plasma clearance rate of indocyanine green necessary to prevent post-hepatectomy liver failure associated with underlying diseases.

Authors:  Nobuhito Nitta; Yusuke Yamamoto; Teiichi Sugiura; Yukiyasu Okamura; Takaaki Ito; Ryo Ashida; Katsuhisa Ohgi; Katsuhiko Uesaka
Journal:  Surg Today       Date:  2021-05-29       Impact factor: 2.549

4.  Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma.

Authors:  Pim B Olthof; Luca Aldrighetti; Ruslan Alikhanov; Matteo Cescon; Bas Groot Koerkamp; William R Jarnagin; Silvio Nadalin; Johann Pratschke; Moritz Schmelze; Ernesto Sparrelid; Hauke Lang; Alfredo Guglielmi; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2020-02-26       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.